Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
JINARC tolvaptan 15 mg + 45 mg tablet blister composite pack, Otsuka Australia Pharmaceutical Pty Ltd, CON-561
Product name
JINARC tolvaptan 15 mg + 45 mg tablet blister composite pack
Sponsor name
Otsuka Australia Pharmaceutical Pty Ltd
Consent start
Consent no.
CON-561
Standard
Section 9(3) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines.
Non-compliance with standard
The strength of the active ingredient is not displayed adjacent to the active
ingredient name; however, the strength is clearly denoted on the labels which
comply with the previous labelling order.
Therapeutic product type
Prescription medicines